San Francisco, 11 December 2025: The Report Neuroprosthetics Market (2025 - 2033) Size, Share & Trends Analysis Report By Type (Motor Prosthetics, Cochlear Implants, Cognitive Prosthetics), By Technology (Deep Brain Stimulation, Spinal Cord Stimulation), By Application, By Region, And Segment Forecasts
The global neuroprosthetics market size is expected to reach USD 47.0 billion by 2033, registering a CAGR of 13.69% from 2025 to 2033, according to a new report by Grand View Research, Inc. The increasing prevalence of neurological disorders coupled with the demand for cost-effective and technologically advanced implants is expected to drive the demand for neuroprosthetics market in the coming years.
In addition, the associated high costs and side effects of conventional medications are responsible for the rising adoption rate of implants. For instance, the increasing adoption of Vagus Nerve Stimulation (VNS) therapy system over therapeutics such as antidepressants in the treatment of Alzheimer's disease, brain aneurysm, and strokes is propelling the overall market growth.
Moreover, the rising geriatric population prone to epilepsy opting for neural implantation over the conventional medication is exerting a positive effect on the overall industry growth. The market is driven by the increasing prevalence of neurological, cardiac, and kidney disorders, as well as ongoing advancements in medical technology.
Request sample report of Neuroprosthetics Market@ https://www.grandviewresearch.com/industry-analysis/neuroprosthetics-market/request/rs1
In addition, expanded research efforts and a greater focus on industry growth are anticipated to support the market in the coming years. The burden of neurological disorders such as Parkinsonâs disease, epilepsy, Alzheimerâs disease, and depression is increasing significantly, which is anticipated to propel the demand for neuroprosthetic devices. According to the WHO data published in February 2024, approximately 50 million people worldwide are living with epilepsy. Furthermore, the burden of neurological disorders remains significant across various demographic groups, contributing to the rising demand for neuroprosthetic devices. According to the CDC, approximately 2.9 million U.S. adults aged 18 and older reported having active epilepsy during 2021 and 2022.
Furthermore, the increasing prevalence of physiological disorders, particularly those affecting the auditory, ophthalmic, cardiac, and renal systems, is expected to drive market growth. According to WHO data published in February 2025, around 2.5 billion people may experience some extent of hearing loss by 2050, with over 700 million requiring hearing rehabilitation.
Currently, over 430 million individuals, representing more than 5% of the global population, including 34 million children, require rehabilitation for hearing loss. This number is projected to exceed 700 million, or about 1 in 10 people, by 2050. Around 80% of those with hearing loss live in low- and middle-income countries, and prevalence rises with age, affecting over 25% of adults above 60. This increasing global burden of auditory disorders is expected to drive demand for cochlear implants and support market expansion during the forecast period.
